Chimeric Therapeutics【CHM】銘柄情報

Chimeric Therapeutics Limited (CHM) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.068

( 4.62% )

買値

0.066

売値

0.07

出来高

358,593

0.065 日の範囲 0.071

0.001 52 週間の範囲 0.20

時価総額

3.616M

前日終値

0.065

始値

0.068

時刻

473

0.066

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

AUD 149,838

発行済株式数

53,181,726

配当利回り

PER

-0.09

1 株当たり利益 (EPS)

-0.75

歳入

9.75M

純利益

-18.79M

Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies for oncology in Australia. The company develops CHM CDH17-directed CAR T cell therapy for the treatment of advanced colorectal cancer, gastric cancer, and intestinal neuroendoc... Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies for oncology in Australia. The company develops CHM CDH17-directed CAR T cell therapy for the treatment of advanced colorectal cancer, gastric cancer, and intestinal neuroendocrine tumors; and CHM CLTX, a chlorotoxin-directed CAR T cell therapy to treat patients with recurrent or progressive glioblastoma and membrane-bound matrix metalloproteinase-2 (MMP2) expressing solid tumors. It also develops CHM CORE-NK for the treatment of acute myeloid leukaemia/colorectal cancer, acute myeloid cancer, blood cancer, solid tumors, MMP2 expressing solid tumors, and CDH17 expressing solid tumors. The company was incorporated in 2020 and is based in Carlton, Australia. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.chimerictherapeutics.com

本社

Carlton, Australia

設立

2026

Chimeric Therapeutics Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker CHM. The last closing price for Chimeric Therapeutics was AUD0.07. Over the last year, Chimeric Therapeutics shares have traded in a share price range of AUD 0.001 to AUD 0.20.

Chimeric Therapeutics currently has 53,181,726 shares in issue. The market capitalisation of Chimeric Therapeutics is AUD3.62 million. Chimeric Therapeutics has a price to earnings ratio (PE ratio) of -0.09.

China Healthcare Acquisition Corp. Announces Stockholder Approval of Charter Amendment to Permit Early Distribution of Its Trust

PASADENA, Calif., March 5 /PRNewswire-FirstCall/ -- China Healthcare Acquisition Corp. (the "Company") (NYSE Alternext US: CHM, CHM-U, CHM-WS...

China Healthcare Acquisition Announces Record Date for Trust Fund Distribution

PASADENA, Calif., Feb. 20 /PRNewswire-FirstCall/ -- China Healthcare Acquisition Corp. (the "Company") (NYSE Alternext US: CHM, CHM-U, CHMW...

Worldwide Electronic Lab Notebooks Industry Symposium Co-Sponsored by Synthematix, Symyx IntelliChem & Waters, Apr 4-5 in Boston

Worldwide Electronic Lab Notebooks Industry Symposium Co-Sponsored by Synthematix, Symyx IntelliChem & Waters, Apr 4-5 in Boston BOSTON, March 24...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.003	4.61538461538	0.065	0.071	0.065	132204	0.06841121	DE
4	-0.032	-32	0.1	0.14	0.065	234721	0.08389442	DE
12	0.066	3300	0.002	0.2	0.001	502481	0.0361909	DE
26	0.065	2166.66666667	0.003	0.2	0.001	2913023	0.00478114	DE
52	0.064	1600	0.004	0.2	0.001	6242768	0.00366759	DE
156	0.031	83.7837837838	0.037	0.2	0.001	4073514	0.00952672	DE
260	-0.217	-76.1403508772	0.285	0.375	0.001	2660909	0.02484309	DE